EKTAY
Price
$4.92
Change
+$0.03 (+0.61%)
Updated
Aug 29 closing price
Capitalization
1.88B
SMMNY
Price
$27.65
Change
-$0.04 (-0.14%)
Updated
Aug 29 closing price
Capitalization
61.88B
67 days until earnings call
Interact to see
Advertisement

EKTAY vs SMMNY

Header iconEKTAY vs SMMNY Comparison
Open Charts EKTAY vs SMMNYBanner chart's image
Elekta AB
Price$4.92
Change+$0.03 (+0.61%)
Volume$3.84K
Capitalization1.88B
Siemens Healthineers AG
Price$27.65
Change-$0.04 (-0.14%)
Volume$20.38K
Capitalization61.88B
EKTAY vs SMMNY Comparison Chart in %
Loading...
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EKTAY vs. SMMNY commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKTAY is a Hold and SMMNY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (EKTAY: $4.93 vs. SMMNY: $27.69)
Brand notoriety: EKTAY and SMMNY are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: EKTAY: 72% vs. SMMNY: 68%
Market capitalization -- EKTAY: $1.88B vs. SMMNY: $61.88B
EKTAY [@Medical/Nursing Services] is valued at $1.88B. SMMNY’s [@Medical/Nursing Services] market capitalization is $61.88B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKTAY’s FA Score shows that 1 FA rating(s) are green whileSMMNY’s FA Score has 1 green FA rating(s).

  • EKTAY’s FA Score: 1 green, 4 red.
  • SMMNY’s FA Score: 1 green, 4 red.
According to our system of comparison, both EKTAY and SMMNY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKTAY’s TA Score shows that 3 TA indicator(s) are bullish while SMMNY’s TA Score has 7 bullish TA indicator(s).

  • EKTAY’s TA Score: 3 bullish, 7 bearish.
  • SMMNY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SMMNY is a better buy in the short-term than EKTAY.

Price Growth

EKTAY (@Medical/Nursing Services) experienced а -5.65% price change this week, while SMMNY (@Medical/Nursing Services) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

Reported Earning Dates

SMMNY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMNY($61.9B) has a higher market cap than EKTAY($1.88B). EKTAY has higher P/E ratio than SMMNY: EKTAY (65.21) vs SMMNY (24.60). SMMNY YTD gains are higher at: 6.903 vs. EKTAY (-11.148). SMMNY has higher annual earnings (EBITDA): 4.68B vs. EKTAY (2.21B). EKTAY has more cash in the bank: 2.95B vs. SMMNY (2.77B). SMMNY has less debt than EKTAY: SMMNY (735M) vs EKTAY (7.57B). SMMNY has higher revenues than EKTAY: SMMNY (23.4B) vs EKTAY (18B).
EKTAYSMMNYEKTAY / SMMNY
Capitalization1.88B61.9B3%
EBITDA2.21B4.68B47%
Gain YTD-11.1486.903-161%
P/E Ratio65.2124.60265%
Revenue18B23.4B77%
Total Cash2.95B2.77B106%
Total Debt7.57B735M1,030%
FUNDAMENTALS RATINGS
EKTAY vs SMMNY: Fundamental Ratings
EKTAY
SMMNY
OUTLOOK RATING
1..100
1677
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
8862
PRICE GROWTH RATING
1..100
7858
P/E GROWTH RATING
1..100
679
SEASONALITY SCORE
1..100
8590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKTAY's Valuation (8) in the null industry is in the same range as SMMNY (17). This means that EKTAY’s stock grew similarly to SMMNY’s over the last 12 months.

SMMNY's Profit vs Risk Rating (74) in the null industry is in the same range as EKTAY (100). This means that SMMNY’s stock grew similarly to EKTAY’s over the last 12 months.

SMMNY's SMR Rating (62) in the null industry is in the same range as EKTAY (88). This means that SMMNY’s stock grew similarly to EKTAY’s over the last 12 months.

SMMNY's Price Growth Rating (58) in the null industry is in the same range as EKTAY (78). This means that SMMNY’s stock grew similarly to EKTAY’s over the last 12 months.

EKTAY's P/E Growth Rating (6) in the null industry is significantly better than the same rating for SMMNY (79). This means that EKTAY’s stock grew significantly faster than SMMNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKTAYSMMNY
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
48%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 8 days ago
63%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 25 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
51%
Aroon
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 3 days ago
49%
View a ticker or compare two or three
Interact to see
Advertisement
EKTAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBHLX19.84N/A
N/A
BBH Partner Fund - International Eq I
CCIZX175.12N/A
N/A
Columbia Seligman Tech & Info Inst
DRRYX16.22N/A
N/A
BNY Mellon Global Real Return - Y
AEDFX12.41N/A
N/A
Water Island Event-Driven Fund R
FEKFX17.53N/A
N/A
Fidelity Equity-Income K6

EKTAY and

Correlation & Price change

A.I.dvisor tells us that EKTAY and SAUHY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKTAY and SAUHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKTAY
1D Price
Change %
EKTAY100%
+0.51%
SAUHY - EKTAY
31%
Poorly correlated
-1.61%
SMMNY - EKTAY
29%
Poorly correlated
-0.14%
PHG - EKTAY
29%
Poorly correlated
N/A
GNGBY - EKTAY
26%
Poorly correlated
+0.37%
NEOG - EKTAY
26%
Poorly correlated
N/A
More

SMMNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMNY has been loosely correlated with SAUHY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SMMNY jumps, then SAUHY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMNY
1D Price
Change %
SMMNY100%
-0.14%
SAUHY - SMMNY
48%
Loosely correlated
-1.61%
CZMWY - SMMNY
44%
Loosely correlated
-0.49%
ESLOY - SMMNY
38%
Loosely correlated
-0.86%
ALC - SMMNY
37%
Loosely correlated
+0.47%
PHG - SMMNY
34%
Loosely correlated
N/A
More